Trials / Completed
CompletedNCT01114893
Travoprost Five Day Posology Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of three concentrations of travoprost ophthalmic solution (Groups A, B and C) administered eight times daily.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost 0.004% | 1 drop in each eye once daily for five days, and 1 drop vehicle in each eye 7 times daily for 5 days |
| DRUG | Travoprost Vehicle | 1 drop in each eye 8 times daily for 5 days |
| DRUG | Travoprost (Groups A, B and C) | 1 drop in each eye 8 times daily for 5 days |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-05-01
- First posted
- 2010-05-03
- Last updated
- 2011-06-23
- Results posted
- 2011-06-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01114893. Inclusion in this directory is not an endorsement.